Korean drug companies urged to explore overseas markets

Korean pharmaceutical firms should look to advance into overseas market, amid the government’s relentless price cut and fiercer competition in already saturated domestic market, according to a local analyst.

Analyst Shin Ji-won of Mirae Asset Securities Co. said in a report that the overseas markets would make answers for local pharmaceutical firms to achieve their annual sales targets, citi...